Archive · 1 Jul 2025
Megasoft to Sell Extrovis AG Stake for $15 Million
Megasoft Limited is selling a part of its business, specifically its share in a Swiss company called Extrovis AG.
They're selling about 36.5% of Extrovis AG to another company, Refex Life Sciences.
The deal is worth $15 million, which is roughly 128 crore rupees.
The company's board of directors has already said yes to the sale.
Now, they need the approval of their shareholders, which will be done through a special vote sent by mail.
Megasoft Limited plans to sell its 36.52% stake in Extrovis AG.
The stake is being sold to Refex Life Sciences Private Limited.
The sale price is set at $15 million (approximately ₹128 crore).
The board of directors has approved the sale.
Shareholder approval will be sought through a postal ballot.
- Who
- Megasoft Limited is selling to Refex Life Sciences Private Limited.
- What
- Megasoft Limited is selling its stake in Extrovis AG.
- When
- The decision was announced on July 1, 2025.
- Where
- Extrovis AG is based in Switzerland.
- Why
- Not explicitly stated in the provided article.
- Company Selling
- Megasoft Limited
- Stake Being Sold
- 36.52% in Extrovis AG
- Buyer
- Refex Life Sciences Private Limited
- Sale Price
- $15 million (₹128 crore)
- Approval Required
- Shareholder approval via postal ballot